BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31693842)

  • 1. Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis.
    Yoo J; Lee JM; Joo I; Lee DH; Yoon JH; Kang HJ; Ahn SJ
    Ultrasonography; 2020 Apr; 39(2):121-129. PubMed ID: 31693842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
    Hwang SM; Cho KY
    Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
    Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
    Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease.
    Yoo J; Lee JM; Joo I; Lee DH; Yoon JH; Kang HJ; Ahn SJ
    Ultrasound Med Biol; 2019 Oct; 45(10):2688-2696. PubMed ID: 31320150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
    Bao J; Lv Y; Wang K; Wang Q; Chen Y; Dong Y; Zhu Y; Wang W
    J Ultrasound Med; 2023 Jul; 42(7):1481-1489. PubMed ID: 36583414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
    Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
    Eur Radiol; 2019 Dec; 29(12):6499-6507. PubMed ID: 31175413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children.
    Dardanelli EP; Orozco ME; Oliva V; Lutereau JF; Ferrari FA; Bravo MG; Ruvinsky S; Roel M; Barvosa PC; Armeno M; Kaplan JS
    Pediatr Radiol; 2023 Jul; 53(8):1618-1628. PubMed ID: 36869263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging.
    Rehman A; Darira J; Hamid K; Ahmed MS; Shazlee MK; Amirali A
    Cureus; 2022 Mar; 14(3):e23435. PubMed ID: 35494925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Diagnosis of Nonalcoholic Fatty Liver Disease with Ultrasound Attenuation Imaging in a Biopsy-Proven Cohort.
    Huang YL; Bian H; Zhu YL; Yan HM; Wang WP; Xia MF; Dong Y; Gao X
    Acad Radiol; 2023 Sep; 30 Suppl 1():S155-S163. PubMed ID: 37407373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.
    Han A; Labyed Y; Sy EZ; Boehringer AS; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Eur Radiol; 2018 Dec; 28(12):4992-5000. PubMed ID: 29869170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Feasibility of Quantitative Ultrasound Imaging for Suspected Hepatic Steatosis: Intra- and Inter-examiner Reliability and Correlation with Controlled Attenuation Parameter.
    Jeon SK; Lee JM; Joo I
    Ultrasound Med Biol; 2021 Mar; 47(3):438-445. PubMed ID: 33277108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
    Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
    Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.
    Tada T; Iijima H; Kobayashi N; Yoshida M; Nishimura T; Kumada T; Kondo R; Yano H; Kage M; Nakano C; Aoki T; Aizawa N; Ikeda N; Takashima T; Yuri Y; Ishii N; Hasegawa K; Takata R; Yoh K; Sakai Y; Nishikawa H; Iwata Y; Enomoto H; Hirota S; Fujimoto J; Nishiguchi S
    Ultrasound Med Biol; 2019 Oct; 45(10):2679-2687. PubMed ID: 31277922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reader agreement and accuracy of ultrasound features for hepatic steatosis.
    Hong CW; Marsh A; Wolfson T; Paige J; Dekhordy SF; Schlein AN; Housman E; Deiranieh LH; Li CQ; Wasnik AP; Jang HJ; Dietrich CF; Piscaglia F; Casola G; O'Boyle M; Richman KM; Valasek MA; Andre M; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Jan; 44(1):54-64. PubMed ID: 29951900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of Performing Multiparametric Ultrasound in Adult Livers.
    Gao J; Lee R; Trujillo M
    J Ultrasound Med; 2022 Mar; 41(3):699-711. PubMed ID: 33982805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.
    Zhao Y; Jia M; Zhang C; Feng X; Chen J; Li Q; Zhang Y; Xu W; Dong Y; Jiang Y; Liu Y; Huang P
    Sci Rep; 2022 Feb; 12(1):2876. PubMed ID: 35190618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability.
    Jesper D; Klett D; Schellhaas B; Pfeifer L; Leppkes M; Waldner M; Neurath MF; Strobel D
    IEEE J Transl Eng Health Med; 2020; 8():1800409. PubMed ID: 32617199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
    Han A; Zhang YN; Boehringer AS; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Eur Radiol; 2019 Sep; 29(9):4699-4708. PubMed ID: 30783789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the number of valid measurements for the attenuation coefficient to assess hepatic steatosis in MAFLD patients: A study of 139 patients who underwent liver biopsy.
    Li X; Huang X; Cheng G; Liang J; Qiu L; Zhang J; Yao Q; Ding H
    Ultraschall Med; 2023 Dec; ():. PubMed ID: 38081211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.